Yet, the expectation from all of this healthcare-generated data is that we in primary care, primarily, will be the ones reviewing all of it, dealing with it, getting back to our patients about it, ...

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...

The latest update is out from Mind Medicine ( (MNMD) ).

Too often, health systems focus on the areas that feel most controllable, like cost containment and quality measures, while underestimating the long-term ROI of strategies like preventive care and ...

Food and Drug Administration no longer agreed that clinical data for the Dutch company's gene therapy for Huntington's disease may be adequate for a marketing application, triggering a 57% slump in ...

Meet some of the team behind UConn Health's effort to improve health care quality, address patient disparities with more REL ...

Investors are watching for private updates on the job market as the government shutdown is days away from becoming the ...

UnitedHealth's Q3 earnings surpassed expectations, breaking a missing streak and signaling a potential operational turnaround ...

Pasadena health tech startup IO Health Technologies secured a $2-million seed round led by Nina Capital to scale its AI ...

UTime (WTO) outlined its ongoing exploration in the field of health data analysis, particularly the potential application of artificial ...

Wes Edwards, chief financial officer of primary and urgent care chain Med First, pulls no punches when it comes to money and health care. “We’re a for-profit entity that believes that the more margin ...

The pharmaceutical world offers a valuable blueprint on how to harness AI’s efficiency while protecting trust, ethics and above all, people.